Amylyx Pharmaceuticals In... (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

5.46

0.32 (6.23%)

At close: May 02, 2025, 2:32 PM

Amylyx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-301.74M	49.27M	-198.38M	-87.93M	-42.28M	-13.72M
Depreciation & Amortization	904K	1.09M	487K	52K	1K	n/a
Stock-Based Compensation	33.04M	37.16M	21.71M	3.14M	243K	108K
Other Working Capital	n/a	-81.54M	21.58M	3.92M	1.18M	2.22M
Other Non-Cash Items	100.15M	-9.94M	-2.06M	5.23M	1.74M	-583K
Deferred Income Tax	n/a	n/a	n/a	121K	1M	n/a
Change in Working Capital	n/a	-65.66M	-1.64M	4.59M	2.6M	3.5M
Operating Cash Flow	-167.65M	11.92M	-179.87M	-74.8M	-36.7M	-10.69M
Capital Expenditures	-157K	-1.24M	-2.53M	-353K	-151K	n/a
Cash Acquisitions	n/a	n/a	236.46M	-3M	n/a	n/a
Purchase of Investments	-231.99M	-300.83M	-415.87M	-49.05M	n/a	n/a
Sales Maturities Of Investments	344M	394.12M	179.41M	3M	n/a	n/a
Other Investing Acitivies	-36.2M	n/a	-236.46M	3M	n/a	n/a
Investing Cash Flow	75.65M	92.05M	-238.99M	-46.41M	-151K	n/a
Debt Repayment	n/a	n/a	n/a	25.9M	16.82M	641K
Common Stock Repurchased	n/a	-3.31M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	348K	3.54M	-658K	-2.39M	48K	27K
Financial Cash Flow	348K	3.54M	431.79M	158.51M	46.82M	668K
Net Cash Flow	-92.08M	107.67M	12.87M	37.31M	9.97M	-10.02M
Free Cash Flow	-167.8M	10.68M	-182.4M	-75.15M	-36.85M	-10.69M